Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. Class A Common Stock (LIMN) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
limn · market cap & enterprise value · FMP · as of Jun 9, 2026
Core market cap & key metrics
As of Jun 9, 2026, Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a market cap — also referred to as its net worth or valuation — of $3,837,177, making it one of the top most valuable companies globally. Market Cap = $0.14 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a market cap — also referred to as its net worth or valuation — of $3,837,177 as of Jun 9, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Liminatus Pharma, Inc. Class A Common Stock reached its all-time high market cap of $2.7B on Jun 24, 2025. Comparing the Liminatus Pharma, Inc. Class A Common Stock market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Liminatus Pharma, Inc. Class A Common Stock net worth vs peers and ask how Liminatus Pharma, Inc. Class A Common Stock valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
LIMN market cap · 6 questionsLiminatus Pharma, Inc. Class A Common Stock's net worth — measured as market capitalization — is $3,837,177 as of Jun 9, 2026. It ranks #0 globally. Market Cap = $$0.14 (price) × shares outstanding.